A review of the genotoxicity of marketed pharmaceuticals

Mutation Research - Reviews in Mutation Research

Volumn 488, Issue 2, 2001, Pages 151-169

  Snyder, Ronald D ^a   Green, John W ^a  

^a DUPONT COMPANY   (United States)

Author keywords

Carcinogenicity; Genotoxicity; Pharmaceuticals; Physician's Desk Reference

Indexed keywords

ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTINEOPLASTIC AGENT; CARCINOGEN; DECONGESTIVE AGENT; NUCLEOSIDE; PEPTIDE; STEROID;

BIOASSAY; CARCINOGENICITY; CYTOGENETICS; DRUG MARKETING; DRUG STRUCTURE; GENETIC TOXICOLOGY; GENOTOXICITY; LITERATURE; LYMPHOMA; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SISTER CHROMATID EXCHANGE;

ANIMALS; CARCINOGENICITY TESTS; CARCINOGENS; DRUG APPROVAL; DRUG TOXICITY; HUMANS; MARKETING OF HEALTH SERVICES; MICE; MUTAGENICITY TESTS; MUTAGENS; REFERENCE BOOKS, MEDICAL;

BACTERIA (MICROORGANISMS); MAMMALIA; RODENTIA;

EID: 0035012857     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(01)00055-2     Document Type: Review

References (11)

1. Galloway S. Cytotoxicity and chromosome aberrations in vitro: experience in industry and the case for an upper limit on toxicity in the aberration assay. Environ. Mol. Mutagen. 35:2000;191-201.
2. Broschinski L., Madle S., Hensel C. Genotoxicity tests for new chemicals in Germany: routine in vitro test systems. Mutat. Res. 418:1998;121-129.
3. Muller L., Kasper P. Human biological relevance and the use of threshold-arguments in regulatory genotoxicity assessment: experience with pharmaceuticals. Mutat. Res. 464:2000;19-34.
4. Caldwell J. Perspective on the usefulness of the mouse lymphoma assay as an indicator of a genotoxic carcinogen: ten compounds which are positive in the mouse lymphoma assay but are not genotoxic carcinogens. Terat. Carcinogen. Mutagen. 13:1993;185-190.
5. Muller L., Sofuni T. Appropriate levels of cytotoxicity for genotoxicity tests using mammalian cells in vitro. Environ. Mol. Mutagen. 35:2000;202-205.
6. Ashby J., Tennant R.W. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the US NTP. Mutat. Res. 257:1991;229-306.
7. Haseman J.K., Zeiger E., Shelby M.D., Margolin B.H., Tennant R.W. Predicting rodent carcinogenicity from four in vitro genetic toxicity assays: an evaluation of 114 chemicals studies by the national toxicology program. J. Am. Statist. Assoc. 85:1990;964-971.
8. Lovell D.P. Screening for possible human carcinogens and mutagens false positives, false negatives: statistical implications. Mutat. Res. 213:1989;43-60.
9. Kim B.S., Margolin B.H. Prediction of rodent carcinogenicity utilizing a battery of in vitro and in vivo genotoxicity tests. Environ. Mol. Mutagen. 34:1999;297-304.
10. Piegorsch W.W., Carr G.J., Portier C.J., Hoel D.G. Concordance of carcinogenic response between rodent species: potency dependence and potential underestimation. Risk Anal. 12:1992;115-121.
11. Haseman J.L., Clark A.M. Carcinogenicity results for 114 laboratory animal studies used to assess the predictivity of four in vitro genetic toxicity assays for rodent carcinogenicity. Environ. Mol. Mutagen. 16(Suppl. 18):1990;15-31.